A. Col

Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial

M. Sebag, R. Kotb, M. Lalancette, 2016 .

Cartilage Implantation in Head and Neck Surgery: Report of a National Survey

P. Donald, A. Col, 1982, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome (SDd) in Patients with Multiple Myeloma (MM) Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs: Results of Phase 1b Study of SDd

D. Sullivan, G. Schiller, M. Sebag, 2018, Blood.

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma.

J. Shah, D. Reece, P. Neri, 2018, Blood.